TP53 and hepatocellular carcinoma: Studies have also shown that the TP53 p.R249S mutation is more common in HBV- and aflatoxin-associated HCC than in HCC associated with other etiologies in peripheral blood, and the detection of the TP53 p.R249S mutation shows promise but may only be highly specific for HCC in certain regions and races.